XML 51 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Deficiency) (Details Narrative) - USD ($)
3 Months Ended
Mar. 12, 2019
Mar. 06, 2019
Feb. 07, 2019
Jan. 03, 2019
Mar. 31, 2019
Mar. 31, 2018
Gross proceeds raised in private placement offering $ 2,704,000       $ 2,317,276 [1] [1]
Aggregate number of shares sold in the offering 2,329,615          
Purchase price of shares sold $ 1.15          
Placement agent's entitlement description A warrant to purchase such number of shares of the Company's common stock equal to 8% of the total shares of common stock sold in the Offering or 188,108 shares          
Stock-based compensation         82,720 $ 137,376
Unrecognized stock-based compensation expense         $ 680,246  
Weighted average remaining vesting period         1 year 4 months 24 days  
Chief Executive Officer [Member]            
Aggregate number of shares sold in the offering 18,382          
Purchase price of shares sold $ 1.36          
Non-Qualified Stock Options [Member] | H. Chris Sarner [Member]            
Stock price     $ 1.59      
Non-Qualified Stock Options [Member] | H. Chris Sarner [Member] | First Anniversary of Ms. Sarner's Employment [Member]            
Number of options vested     50,000      
Non-Qualified Stock Options [Member] | H. Chris Sarner [Member] | Quarterly Basis [Member]            
Number of options vested     100,000      
Non-Qualified Stock Options [Member] | H. Jorge Ulloa [Member]            
Number of stock option grants     30,000      
Exercise price of options granted     $ 1.59      
Options term     1 year      
Options grant date fair value     $ 0.58      
Options aggregate grant date fair value     $ 17,400      
Stock price     $ 1.59      
Risk-free interest rate     2.47%      
Volatility     36.10%      
Annual rate of quarterly dividends     0.00%      
Contractual term     5 years 3 months 19 days      
Non-Qualified Stock Options [Member] | Dr. Peter Pappas [Member]            
Number of stock option grants   20,000        
Exercise price of options granted   $ 1.38        
Options grant date fair value   $ 0.50        
Options aggregate grant date fair value   $ 10,000        
Stock price   $ 1.38        
Risk-free interest rate   2.50%        
Volatility   35.90%        
Annual rate of quarterly dividends   0.00%        
Contractual term   5 years 3 months 19 days        
MZ Agreement [Member]            
Received compensation per month, value     $ 8,000      
MZ Agreement [Member] | Restricted Stock [Member]            
Number of restricted shares vested     85,000      
Alere Agreement [Member] | Alere Financial Partners [Member]            
Warrants term       5 years    
Monthly fee       $ 7,500    
Number of warrants to purchase shares of common stock       35,000    
Warrants exercise price       $ 1.59    
Warrants vesting term       12 months    
Alere Agreement [Member] | Placement Agent [Member]            
Number of warrants to purchase shares of common stock       188,108    
Warrants exercise price       $ 1.50    
Employment Agreement [Member] | Non-Qualified Stock Options [Member] | H. Chris Sarner [Member]            
Options aggregate grant date fair value     $ 87,000      
Award Agreement [Member] | April 2019 [Member]            
Number of units forfeited         29,183  
[1] Net of cash offering costs of $386,724